Share ownership Novo Nordisk A/S

NOVO B

DK0062498333

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 13:15:18 12/02/2026 GMT			5-day change	1st Jan Change
307.95 ^DKK	+0.41%		+9.69%	-5.35%

01:09pm	Jefferies Upgrades Novo Nordisk to Hold From Underperform, Adjusts Price Target to $43.90 From $42.10	MT
12:58pm	West Pharma forecasts 2026 profit above estimates on strong demand for drug components	RE

Share class: Novo Nordisk A/S

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	10	1,075,000,000	0	0	70.25 %
Stock B	1	3,390,000,000	3,136,564,503 ( 92.52 %)	24,000,000 ( 0.708 %)

Major shareholders: Novo Nordisk A/S

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 5.238 %	177,560,500	5.238 %	10 453 M kr
NOVO NORDISK A/S 0.5393 %	18,283,326	0.5393 %	1 076 M kr
Nykredit Bank A/S (Investment Management) 0.1474 %	4,997,158	0.1474 %	294 M kr
Nordea Investment Management AB 0.1399 %	4,741,771	0.1399 %	279 M kr
Sjunde AP-fonden 0.1398 %	4,738,475	0.1398 %	279 M kr
ODIN Forvaltning AS 0.1355 %	4,593,090	0.1355 %	270 M kr
State Street Global Advisors Ltd. 0.1268 %	4,298,182	0.1268 %	253 M kr
ACATIS Investment Kapitalverwaltungsgesellschaft mbH 0.1107 %	3,752,199	0.1107 %	221 M kr
Capfi Delen Asset Management NV 0.0832 %	2,819,753	0.0832 %	166 M kr
Storebrand Asset Management AS 0.0813 %	2,755,326	0.0813 %	162 M kr
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Caixa DTVM SA 0.000011 %	2,970	0.000011 %	22 294 kr

Name	Equities	%	Valuation
Novo Holdings A/S (Investment Company) 100 %	1,074,872,000	100 %	63 280 M kr
ANIMA Sgr SpA 0.0108 %	115,783	0.0108 %	7 M kr
Russell Investments Ltd. 0.000038 %	405	0.000038 %	23 843 kr

Name	Equities	%	Valuation
Capital Research & Management Co. (International Investors) 0.5225 %	17,713,424	0.5225 %	1 053 M kr
Loomis, Sayles & Co. LP 0.4768 %	16,165,468	0.4768 %	961 M kr
Fidelity Management & Research Co. LLC 0.4152 %	14,075,391	0.4152 %	837 M kr
Fiduciary Trust Company International 0.4125 %	13,984,789	0.4125 %	831 M kr
Merrill Lynch International 0.3954 %	13,403,378	0.3954 %	797 M kr
Eaton Vance Management 0.3662 %	12,413,429	0.3662 %	738 M kr
Goldman Sachs Wealth Services LP 0.3241 %	10,986,778	0.3241 %	653 M kr
Folketrygdfondet 0.3012 %	10,211,913	0.3012 %	607 M kr
Fisher Asset Management LLC 0.2886 %	9,784,222	0.2886 %	581 M kr
Wells Fargo Bank NA 0.223 %	7,559,665	0.223 %	449 M kr
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	47.72%
Other	1.19%
Novo Nordisk A/S	0.54%
State Street Corp.	0.18%
Markel Group, Inc.	0.08%
Banco Bilbao Vizcaya Argentaria SA	0.01%
SEI Investments Co.	0.01%
Menora Mivtachim Holdings Ltd.	0.01%
Unknown	50.26%

Based on 1000 largest holdings

Geographical origin of shareholders

Denmark	37.73%
United States	7.51%
United Kingdom	1.1%
Norway	0.81%
Canada	0.44%
Sweden	0.4%
Germany	0.32%
Spain	0.18%
Finland	0.17%
Luxembourg	0.16%
Ireland	0.13%
France	0.13%
Belgium	0.1%
Switzerland	0.09%
Netherlands	0.08%
Australia	0.06%
Italy	0.06%
Austria	0.05%
New Zealand	0.03%
South Africa	0.02%
Japan	0.02%
Singapore	0.02%
Slovenia	0.02%
Israel	0.02%
Hong Kong	0.02%
Mexico	0.01%
Portugal	0.01%
Liechtenstein	0.01%
Iceland	0.01%
Puerto Rico	0.01%

Based on 1000 largest holdings

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (93.7%); - rare disease treatment products (6.3%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe and Canada (21.4%), the United States (56%), Latin America/Middle East/Africa (9.9%), China/Hong Kong/Taiwan (6%), Asia/Pacific (6.7%).

Employees

69,150

Sector

Pharmaceuticals

Calendar

03-26 - Annual General Meeting

More about the company